VNRX

VolitionRx
VNRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$48.84M
EV
$50.20M
Shares Outstanding
100.09M
Beta
1.16

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$2.92
P/E 2025E
-
P/Revenue 2025E
9.60x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About VolitionRx Limited

gainify
VNRX

VolitionRx Limited

VNRX

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test ...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Reynolds, Cameron

Employees

85

IPO Date

2012-03-02

Headquarters

1489 West Warm Springs Road, Suite 110, Henderson, Nevada, 89014, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved